Adverse effects after treatment initiation: injection site reactions, neutropenia, infections, demyelinating disease, heart failure, malignancy, and induction of autoimmunity. · children diagnosed with Kawasaki disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Amputation · patients with in‐stent restenosis of the femoropopliteal arteries
1 finding from 1 review
Target lesion revascularization · patients with in‐stent restenosis of the femoropopliteal arteries
It is very uncertain whether drug‐eluting balloon angioplasty at 6 months changes target lesion revascularization (TLR) compared with uncoated balloon angioplasty at 6 months (very low certainty).
1 finding from 1 review
Binary restenosis · patients with in‐stent restenosis of the femoropopliteal arteries
It is very uncertain whether drug‐eluting balloon angioplasty at 6 months changes binary restenosis compared with uncoated balloon angioplasty at 6 months (very low certainty).
1 finding from 1 review
Death · patients with in‐stent restenosis of the femoropopliteal arteries
It is very uncertain whether drug‐eluting balloon angioplasty at 6 months changes death compared with uncoated balloon angioplasty at 6 months (very low certainty).
1 finding from 1 review
Improvement ≥ 1 Rutherford category · patients with in‐stent restenosis of the femoropopliteal arteries
It is very uncertain whether drug‐eluting balloon angioplasty at 6 months changes improvement ≥ 1 Rutherford category compared with uncoated balloon angioplasty at 6 months (very low certainty).
1 finding from 1 review
Intervention not reported
Deep vein thrombosis (DVT) · Hospitalised patients1
The intervention leads to lower deep vein thrombosis (DVT) (high certainty).
1 finding from 1 review
Intervention not reported
Proximal DVT · Patients hospitalised following acute myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Pulmonary embolism · Patients hospitalised following acute myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse effects and complications · Patients hospitalised following acute myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Proximal DVT · Hospitalised patients1
The intervention probably leads to lower proximal DVT (moderate certainty).
1 finding from 1 review
Intervention not reported
Pulmonary embolism · Hospitalised patients1
The intervention may leads to lower pulmonary embolism (low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects and complications · Hospitalised patients1
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Deep vein thrombosis (DVT) · Patients hospitalised for surgical procedures1
The intervention leads to lower deep vein thrombosis (DVT) (high certainty).
1 finding from 1 review
Intervention not reported
Proximal DVT · Patients hospitalised for surgical procedures1
The intervention probably leads to lower proximal DVT (moderate certainty).
1 finding from 1 review
Intervention not reported
Pulmonary embolism · Patients hospitalised for surgical procedures1
The intervention may leads to lower pulmonary embolism (low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects and complications · Patients hospitalised for surgical procedures1
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Deep vein thrombosis (DVT) · Patients hospitalised following acute myocardial infarction
The intervention may leads to lower deep vein thrombosis (DVT) (low certainty).
1 finding from 1 review
OR 0.12 [0.03, 0.51]
Studies not reported
Low
Primary patency ( · people with peripheral vascular disease requiring above‐knee femoro‐popliteal bypass surgery
Autologous vein may leads to lower primary patency (24 months) compared with other graft types (low certainty).
2 findings from 1 review
OR 0.59 [0.37, 0.94]
Studies not reported
Low
OR 0.47 [0.28, 0.8]
Studies not reported
Moderate
Primary patency ( · people with peripheral vascular disease requiring above‐knee femoro‐popliteal bypass surgery
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
OR 2.08 [1.29, 3.35]
Studies not reported
Low